Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis

Abstract

Colorectal cancer is one of the most common cancers worldwide. However, it is unclear what influence body mass index (BMI) has on colorectal cancer prognosis. We conducted a systematic review and meta-analysis of observational studies to examine the association of BMI with colorectal cancer outcomes. We searched MEDLINE and EMBASE databases from inception to February 2015 and references of identified articles. We selected observational studies that reported all-cause mortality, colorectal cancer-specific mortality, recurrence and disease-free survival according to BMI category. Random-effects meta-analyses were conducted to combine estimates. We included 18 observational studies. Obese patients had an increased risk of all-cause mortality [relative risk (RR) 1.14; 95 % confidence interval (CI) 1.07-1.21], cancer-specific mortality (RR 1.14; 95 % CI 1.05-1.24), recurrence (RR 1.07; 95 % CI 1.02-1.13) and worse disease-free survival (RR 1.07; 95 % CI 1.01-1.13). Underweight patients also had an increased risk of all-cause mortality (RR 1.43; 95 % CI 1.26-1.62), cancer-specific mortality (RR 1.50; 95 % CI 1.20-1.87), recurrence (RR 1.13; 95 % CI 1.05-1.21) and worse disease-free survival (RR 1.27; 95 % CI 1.13-1.43). Overweight patients had no increased risk for any of the outcomes studied. Both obese and underweight patients with colorectal cancer have an increased risk of all-cause mortality, cancer-specific mortality, disease recurrence and worse disease-free survival compared to normal weight patients.

Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project

“…Recent meta-analysis or systematic review papers revealed that uncontrolled diabetes, 14 obesity and underweight, 15 smoking, 16 western dietary pattern, 4 and physical inactivity 4 were correlated with poor overall survival. We found that underweight, smoking, and physically inactivity were all associated with all-cause mortality risk in line with the previous studies.…”

Does postoperative morbidity worsen the oncological outcome after radical surgery for gastrointestinal cancers? A systematic review of the literature

“…have recently conducted a meta‐analysis on the effects of BMI following the diagnosis of colorectal cancer. They have reported that a low BMI is associated with increased all‐cause mortality and cancer‐specific mortality 72. This suggests that underweight patients might have lower nutritional statuses and lower body muscle content than individuals with normal bodyweight.…”

Metabolic disorders across hepatocellular carcinoma in Italy

“…Features of the metabolic syndrome, such as diabetes and obesity, have been associated with both increased risk of cancer development and cancer‐related mortality regarding both gastrointestinal (colorectal, oesophagus, stomach and pancreas) and extra‐intestinal (kidney and breast) malignancies . The increased oncologic risk would be because of a number of molecular mechanisms (insulin resistance, chronic inflammation, reduced apoptosis and imbalance of gut microbiota) that initiate and fuel carcinogenesis.…”